Furthermore, inhibitor of HMG-CoA reductase (HMGCR), a rate-limiting enzyme of mevalonate pathway, has been demonstrated to exert inhibitory effects on various types of cancers, including breast cancer25–30. The gene discussed is HMGCR; the disease is cancer.